The present invention provides compounds of Formula and a method of treating Alzheimer’s disease using a compound of Formula, wherein: R1 and R2 include alkyl and phenylalkyl; R3 is hydrogen or alkyl; and R4 and R5 include alkyl, alkoxy, carboxyl, alkoxycarbonyl, and nitro. A first insulation layer is formed in the cell region and includes a plurality of holes. In addition, fixed guidance elements, such as physical markers, may be used with the floor mats in order to further identify points where the group of individuals should turn or otherwise alter directions. In a removed position, one of the driving assembly and the driven assembly may be removed in a generally radial direction relative to the frame and the other of the driving assembly and the driven assembly. Afterwards, a closed-loop tracking control operation of the optical disk drive is performed according to the input tracking error signal calibrated with the dynamic offset. The front substrate includes alight shielding layer which defines an opening in the each pixel region, and the opening contains a non-retroreflection region, which is defined by the non-retroreflection member, and a retroreflection region, which is defined by the retroreflective layer.